2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Art. -Nr. Produktname CAS. Nr. Reinheit Chemische Struktur
  • HY-N13996
    Clavamycin B 103080-36-0 98%
    Clavamycin B has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin B
  • HY-N13997
    Clavamycin C 103059-94-5 98%
    Clavamycin C has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin C
  • HY-N13998
    Cephalonic acid 18456-04-7 98%
    Cephalonic acid is a pentaprenyl terpenoid compound that can be isolated from the fermentation broth of Cephaloscorlum caerulens. Cephalonic acid has weak antibacterial activity against Staphylococcus aureus.
    Cephalonic acid
  • HY-N13999
    Clavamycin D 103059-95-6 98%
    Clavamycin D has strong anti-candida activity, and its action can be antagonized by dipeptide or tripeptide, but amino acid can not cancel its action. No antibacterial activity and no inhibition of β-lactamase.
    Clavamycin D
  • HY-N14003
    Clavamycin E 103059-96-7 98%
    Clavamycin E is a clavam antibiotic.
    Clavamycin E
  • HY-N14005
    Cephamycin A 34279-78-2 98%
    Cephalomycin A shows weak activity against Gram-positive and negative bacteria.
    Cephamycin A
  • HY-N14007
    Cephamycin B 34279-77-1 98%
    Cephalomycin B showes weak activity against Gram-positive and negative bacteria.
    Cephamycin B
  • HY-N14010
    Cationomycin 80394-65-6 98%
    Cationomycin inhibits the activity of Gram-positive bacteria and mycobacterium, but has no effect on Gram-negative bacteria, yeast and fungi. The feed containing 50-100 ppm Cationomycin could effectively prevent coccidiosis of chicken.
    Cationomycin
  • HY-N14011
    Cedarmycin A 363624-69-5 98%
    Cedarmycin A has activities against Candida, Cryptococcus neoforme and Aspergillus fumigatus, with the MIC values of 12.5-50 μg/mL.
    Cedarmycin A
  • HY-N14012
    Cedarmycin B 363624-70-8 98%
    Cedarmycin B has activities against Candida, Cryptococcus neoforme and Aspergillus fumigatus, with the MIC values of 12.5-50 μg/mL.
    Cedarmycin B
  • HY-N14013
    Chondramide A 172430-60-3 98%
    Chondramide A has anti-candida, Henson yeast, lipids yeast, ball-like yeast and other fungal activities, but has no anti-Gram positive and negative bacteria activities.
    Chondramide A
  • HY-N14015
    Cerexin A 55467-31-7 98%
    Cerexin A has anti-Gram-positive bacterial activity.
    Cerexin A
  • HY-N14018
    Glidobactin A 108351-50-4 98%
    Glidobactin A is an acyl peptide antibiotic. Glidobactin A has activity against Candida, Aspergillus fumigatus and Trichophyton, but it is not effective against Candida albicans M-9 infection in mice.
    Glidobactin A
  • HY-N14019
    Glidobactin B 108351-51-5 98%
    Glidobactin B is an anti-tumor antibiotic. Glidobactin B has the activity against pathogenic fungi and yeast. Glidobactin B also extends the survival of mice inoculated with leukemia P388 cells.
    Glidobactin B
  • HY-N14020
    Glidobactin C 108351-52-6 98%
    Glidobactin C (GlbC) is an anti-tumor antibiotic. Glidobactin C (GlbC) has the activity against pathogenic fungi and yeast. Glidobactin C has anti-Candida albicans and Aspergillus fumigatus activity with a MIC of 0.8 μg/mL. Glidobactin C also extends the survival of mice inoculated with leukemia P388 cells.
    Glidobactin C
  • HY-N14022
    Glidobactin F 119259-72-2 98%
    Glidobactin F is an anti-tumor antibiotic. Glidobactin F has the activity against pathogenic fungi and yeast. Glidobactin F also extends the survival of mice inoculated with leukemia P388 cells.
    Glidobactin F
  • HY-N14023
    Glidobactin G 119259-71-1 98%
    Glidobactin G is an anti-tumor antibiotic. Glidobactin G has the activity against pathogenic fungi and yeast. Glidobactin G also extends the survival of mice inoculated with leukemia P388 cells.
    Glidobactin G
  • HY-N14025
    Chicamycin B 89675-39-8 98%
    Chicamycin B has anti-tumor activity and weak anti-Gram-positive bacteria activity.
    Chicamycin B
  • HY-N14027
    Chondramide B 172430-61-4 98%
    Chondramide B has anti-candida, Henson yeast, lipids yeast, ball-like yeast and other fungal activities, but has no anti-Gram positive and negative bacteria activities.
    Chondramide B
  • HY-N14028
    Coriolin A 33404-85-2 98%
    Coriolin A has anti-Gram-positive bacteria, negative bacteria (weak), yeast and vaginal trichomoniasis activities. Coriolin A of 5 μg/mL can inhibit the growth of yoshida sarcoma 61.6%. Coriolin A has no inhibitory effect on Ehrlich ascites carcinoma in animals.
    Coriolin A
Art. -Nr. Produktname / Synonyms Application Reactivity